Advertisement
Australia markets closed
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • AUD/USD

    0.6604
    -0.0017 (-0.25%)
     
  • OIL

    78.32
    -0.94 (-1.19%)
     
  • GOLD

    2,375.60
    +35.30 (+1.51%)
     
  • Bitcoin AUD

    91,710.41
    -2,053.02 (-2.19%)
     
  • CMC Crypto 200

    1,260.70
    -97.30 (-6.95%)
     
  • AUD/EUR

    0.6127
    -0.0011 (-0.17%)
     
  • AUD/NZD

    1.0972
    +0.0004 (+0.03%)
     
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NASDAQ

    18,132.23
    +18.77 (+0.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • Dow Jones

    39,466.26
    +78.50 (+0.20%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript

Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript

My name is Susie Lisa, and as the senior vice president of investor relations for Vertex, it is my pleasure to welcome you to our fourth quarter and full year 2022 financial results conference call. On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex' CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief financial officer.